A special issue of Clinical Gastroenterology and Hepatology is dedicated to the clinical management of hepatic disorders, including nonalcoholic fatty liver disease (NAFLD), viral hepatitis, autoimmune hepatitis, and primary sclerosing cholangitis (PSC).
The issue comprises 14 review articles that aim to present clinicians with evidence-based guidance and expert opinions on management of patients with liver diseases.
W. Ray Kim et al present a comprehensive overview of the burden of chronic, nonmalignant liver disease in the United States. Chronic liver diseases currently cause more than 2 million deaths each year, and incidence is increasing.
Yamini Natarajan and Fasiha Kanwal explain pay-for-performance programs in the United States, which started off as pay-for-performance initiatives, but evolved into a penalty-based program. The authors explain current measures in chronic liver disease, rates of submission, as well as the submission process and associated challenges.
Kavish R. Patidar and Jasmohan S. Bajaj discuss the diagnosis and management of covert and overt hepatic encephalopathy, and Stephen A. Harrison et al describe treatment and prevention strategies, and their outcomes, for patients with NAFLD.